12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

• Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
• Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
• Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

Click Here To Invest For Just $0.80/Share ($1000 Min)

Gainers

• Ayala Pharmaceuticals AYLA stock moved upwards by 85.0% to $1.61 during Tuesday's pre-market session. The company's market cap stands at $22.6 million.
• OpGen OPGN shares rose 14.99% to $0.6. The company's market cap stands at $27.8 million.
• Scopus BioPharma SCPS stock moved upwards by 12.82% to $0.44. The company's market cap stands at $9.2 million.
• Anixa Biosciences ANIX stock increased by 12.42% to $3.8. The market value of their outstanding shares is at $115.7 million.
• Agile Therapeutics AGRX shares increased by 12.12% to $0.56. The company's market cap stands at $17.6 million.
• Synlogic SYBX stock rose 9.9% to $1.11. The market value of their outstanding shares is at $77.9 million.

Losers

• Revelation Biosciences REVB stock fell 34.7% to $0.66 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.9 million.
• Revelation Biosciences REVBU stock declined by 16.73% to $2.34.
• NuCana NCNA stock declined by 10.12% to $2.0. The market value of their outstanding shares is at $104.3 million.
• Tonix Pharmaceuticals TNXP stock declined by 8.1% to $1.59. The company's market cap stands at $50.3 million.
• Heart Test Laboratories HSCS shares decreased by 7.98% to $1.27. The market value of their outstanding shares is at $10.4 million.
• Beam Therapeutics BEAM shares fell 7.96% to $58.88. The company's market cap stands at $4.1 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.